Explainer

What Is the Difference Between Anxiety and Depression? Key Signs

Depression centers on low mood for 2+ weeks; generalized anxiety on hard-to-control worry for 6+ months. Anxiety starts earlier: median age 11 vs. 30 (NCS-R).

Mental Health Stats Research Team 6 min read

Key Takeaways

  • Depression is defined by low mood or lost interest lasting at least 2 weeks, while generalized anxiety disorder is defined by hard-to-control worry on most days for at least 6 months[1][2].2 weeks vs. 6 months[1]
  • The tripartite model holds that both share negative affect, but low positive affect points to depression and physiological hyperarousal points to anxiety[3].[3]
  • In a 2014 study of 468 patients, worry predicted a generalized anxiety disorder diagnosis and rumination predicted major depressive disorder[4].468 patients[4]
  • Anxiety disorders start much earlier: median age of onset was 11 years versus 30 years for mood disorders in the National Comorbidity Survey Replication (2001 to 2003)[5].11 vs. 30 years[5]
  • Separate screeners exist for each: a PHQ-9 score of 10 or more had 88% sensitivity and 88% specificity for major depression, and the GAD-7 reached 89% sensitivity and 82% specificity for GAD[6][7].88% / 89%[6]

What Is the Difference Between Anxiety and Depression?

The difference between anxiety and depression starts with the core feature each diagnosis requires. Depression requires a depressed mood or a loss of interest or pleasure in most activities, present most of the day, nearly every day, for at least 2 weeks[1].

Generalized anxiety disorder, the most studied anxiety diagnosis, requires worry that is difficult to control on most days for at least 6 months, plus at least three of six symptoms such as restlessness, fatigue, muscle tension or sleep problems[2].

Put simply, anxiety is organized around threat and what might go wrong, and depression is organized around loss of mood, interest and drive. The two overlap heavily in practice, which is why the questions below matter.

How often the two occur together is covered in Depression and Anxiety: How Often They Overlap and Why, and how diagnostic manuals classify them is covered in Is Anxiety Depression?. This page focuses on how they differ and how clinicians tell them apart.

How these comparisons are made: the figures below come from different studies, years and settings, including a 2001 to 2003 national survey that used DSM-IV criteria and primary care validation studies of screening questionnaires. They describe groups of patients, not any one person, and a screening score is not a diagnosis.

Anxiety vs. Depression at a Glance

FeatureAnxiety (GAD)Depression (major depression)
Required core featureHard-to-control worryLow mood or loss of interest
Minimum duration6 months2 weeks
Typical thinking styleWorry (future)Rumination
Specific affect patternPhysiological hyperarousalLow positive affect
Body signs more specific to itTrembling, sweating, breathlessnessSlowed down, appetite change
Median age of onset (category)11 years30 years (mood disorders)
Common screenerGAD-7PHQ-9
Category-specific optionsExposure therapy, buspirone, benzodiazepinesIPT, esketamine, ECT, rTMS
Shared optionsCBT, SSRIs, SNRIsCBT, SSRIs, SNRIs

Main differences between generalized anxiety disorder and major depression, drawn from NIMH descriptions, the tripartite model, a 2014 clinical study of worry and rumination, and the National Comorbidity Survey Replication[2][1][3][4][5].

1Age-of-onset medians are for the broad DSM-IV categories of anxiety disorders and mood disorders among U.S. adults surveyed in 2001 to 2003[5].

2Treatment rows list what NIMH describes for each condition; they are not recommendations[2][1][8].

Sources

  • •NIMH, 2024
  • •Anderson & Hope, 2008
  • •Yang et al., 2014
  • •Kessler et al., 2005

Worry vs. Rumination: How the Thinking Differs

Both conditions involve repetitive negative thinking, but the content and direction differ. Worry is the thinking pattern most tied to generalized anxiety disorder, and rumination, the repeated going over of problems and low mood, is most tied to major depression[4].

A 2014 study tested this in 468 patients whose diagnoses were confirmed by structured clinical interview: 148 with generalized anxiety disorder and 320 with major depressive disorder[4]. Worry and rumination loaded on separate factors, worry raised the probability of a GAD diagnosis more than rumination did, and rumination did the same for depression[4].

The NIMH description of GAD gives typical worry targets: job security, health, finances, family members' well-being, being late and household responsibilities[2]. Depression's thinking symptoms run toward hopelessness, pessimism, guilt and worthlessness[1].

The evidence here comes mostly from single studies with clinical samples, so it describes a tendency, not a rule.

Tripartite model of anxiety and depression

A model proposed by Clark and Watson in 1991 to explain why anxiety and depression overlap. It holds that both share high negative affect (general distress), while low positive affect is associated with depression and high physiological hyperarousal is associated with anxiety[3].

Related Terms

negative affect
positive affect
physiological hyperarousal
anhedonia

Source: Anderson & Hope, Clinical Psychology Review, 2008

High Arousal vs. Low Energy: How Anxiety and Depression Feel in the Body

The tripartite model gives the most useful physical distinction. Positive affect covers feeling energetic, interested, enthusiastic and alert, and its absence shows up as feeling tired, fatigued and sluggish; physiological hyperarousal covers somatic tension, shortness of breath, dizziness, lightheadedness and dry mouth[3].

In Clark and Watson's research, people with depression tended to show low positive affect and high negative affect, and people with anxiety disorders tended to show high hyperarousal along with high negative affect[3].

NIMH's symptom lists line up with that split. GAD can involve trembling or twitching, sweating, feeling lightheaded or out of breath, trouble swallowing and frequent bathroom trips[2]. Depression lists fatigue, feeling slowed down, appetite or weight changes, and aches or digestive problems without a clear physical cause[1].

Several symptoms appear on both lists: sleep problems, fatigue, trouble concentrating, irritability and feeling restless or on edge[2][1]. NIMH's depression list even includes a persistent anxious mood[1]. That shared ground is why a symptom checklist alone often cannot separate the two.

The model is not settled. The Anderson and Hope review notes that later studies questioned how well it fits children and whether its factors behave the same way across every anxiety and depressive disorder[3].

Depression vs. Anxiety Disorder: Diagnosis Rules and Types

Anxiety disorder is a family of diagnoses, not one condition. NIMH lists generalized anxiety disorder, panic disorder, social anxiety disorder and phobia-related disorders, and describes them as anxiety that does not go away, shows up in many situations and can worsen over time[9].

Depression also has subtypes. Major depression requires symptoms for at least 2 weeks, while persistent depressive disorder involves milder symptoms that last at least 2 years[1].

So the difference between depression and an anxiety disorder depends on which anxiety disorder is meant. Panic disorder centers on attacks of fear, and phobias center on specific feared objects or situations, while GAD shares the most symptoms with depression, which is why this page uses it as the main comparison.

Age changes how the two present. NIMH notes that depressed children may be anxious or cranky, cling to a parent, refuse to go to school or worry that a parent may die, which can resemble an anxiety disorder[1]. Children and teens with depression may be irritable rather than sad[1].

At the other end of life, older adults with depression may report a lack of emotions rather than a depressed mood[1]. For some people, depression shows up as physical problems such as a racing heart, a tightened chest, chronic headaches or digestive issues, and many men are more likely to see a provider about these than about emotional symptoms[1]. Those complaints sit close to the breathlessness, lightheadedness and tension NIMH lists for GAD, one reason the two get confused[2].

Before either diagnosis, clinicians check for medical look-alikes. NIMH notes that certain medications and conditions such as viruses or thyroid disorders can produce the same symptoms as depression, and a physical exam, interview and lab tests can rule them out[1].

Median age of onset for anxiety disorders vs. mood disorders, U.S. adults (NCS-R, 2001 to 2003)
11 vs. 30 years

Half of people who ever developed an anxiety disorder reported first onset by age 11, compared with age 30 for mood disorders such as major depression. The figures rely on adults recalling when symptoms began.

"Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders."

Kessler et al., Archives of General Psychiatry(2005) View Source

Which Usually Comes First, Anxiety or Depression?

At the population level, anxiety comes first. In the National Comorbidity Survey Replication, a face-to-face household survey of 9,282 English-speaking U.S. adults conducted from 2001 to 2003, the median age of onset was 11 years for anxiety disorders and 30 years for mood disorders[5].

The same survey found that later-onset disorders were mostly comorbid conditions, meaning they appeared in people who already had another disorder[5]. NIMH similarly notes that GAD usually starts in early adulthood and that young adults with depression often also have GAD, social phobia or panic disorder[2][1].

These are group medians for broad categories, so they do not show that anxiety causes depression or that it comes first in any given person. The data are also dated and rely on adults recalling when symptoms began.

Current prevalence by age, sex and state is tracked on the depression statistics page and the anxiety statistics page.

How Screening Tools Separate Anxiety From Depression

Clinics usually screen for the two with separate questionnaires. The PHQ-9 scores each of the nine DSM-IV depression criteria from 0 to 3, and in its 2001 validation study of 6,000 primary care and obstetrics-gynecology patients, a score of 10 or more had 88% sensitivity and 88% specificity for major depression[6]. Scores of 5, 10, 15 and 20 mark mild, moderate, moderately severe and severe depression[6].

The seven-item GAD-7 was validated in 2006 in 15 U.S. primary care clinics, where its best cut point gave 89% sensitivity and 82% specificity for generalized anxiety disorder[7]. In that study, GAD and depression symptoms often occurred together, but factor analysis confirmed them as distinct dimensions with separate effects on disability[7].

In 2023 the U.S. Preventive Services Task Force recommended screening adults 64 and younger for anxiety disorders, a grade B recommendation, and found the evidence insufficient for adults 65 and older[10]. Its review put the GAD-7's pooled sensitivity at 0.79 and specificity at 0.89 at a cutoff of 10 or more[10].

A positive screen on either tool starts a clinical interview rather than ending one. Scoring and accuracy for the depression screener are covered in PHQ-9 Depression Test.

How Treatment for Anxiety and Depression Differs and Overlaps

Much of the treatment is shared. NIMH calls cognitive behavioral therapy the “gold standard” psychotherapy for GAD and lists it as an evidence-based therapy for depression[2][1]. SSRI and SNRI antidepressants are commonly used for depression and can also treat GAD symptoms[2].

Some options are specific to anxiety. NIMH describes exposure therapy, a type of CBT for anxiety disorders, as spending brief periods in a supportive setting learning to tolerate the distress caused by certain items, ideas or imagined scenes[8]. Benzodiazepines can rapidly reduce severe anxiety but carry tolerance and dependence risk, so they may be prescribed only briefly, and buspirone takes 3 to 4 weeks to reach full effect[2].

Others are specific to depression. Interpersonal therapy targets relationships and life events that affect mood, antidepressants usually take 4 to 8 weeks to work, and esketamine nasal spray is FDA-approved for depression that has not improved after at least two antidepressants[1]. Brain stimulation, most often ECT or rTMS, is an option when other depression treatments have not worked[1].

Drug-by-drug trial results are reviewed in Anxiety Medication and Anti-Depression Meds.

Frequently Asked Questions

Sources & References

  1. National Institute of Mental Health. Depression. National Institutes of Health; NIH Publication No. 24-MH-8079. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/publications/depression [Link]
  2. National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. National Institutes of Health. Accessed October 2026. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad [Link]
  3. Anderson ER, Hope DA. A review of the tripartite model for understanding the link between anxiety and depression in youth. Clinical Psychology Review. Published 2008. Accessed October 2026. https://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1591&context=psychfacpub [Link]
  4. Yang MJ, Kim BN, Lee EH, et al. Diagnostic utility of worry and rumination: a comparison between generalized anxiety disorder and major depressive disorder. Psychiatry and Clinical Neurosciences. Published 2014. Accessed October 2026. https://onlinelibrary.wiley.com/doi/10.1111/pcn.12193 [Link]
  5. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. Published 2005. Accessed October 2026. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/208678 [Link]
  6. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. Published 2001. Accessed October 2026. https://link.springer.com/article/10.1046/j.1525-1497.2001.016009606.x [Link]
  7. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine. Published 2006. Accessed October 2026. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410326 [Link]
  8. National Institute of Mental Health. Psychotherapies. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/psychotherapies [Link]
  9. National Institute of Mental Health. Anxiety Disorders. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/anxiety-disorders [Link]
  10. US Preventive Services Task Force. Anxiety Disorders in Adults: Screening. Final Recommendation Statement. Published June 20, 2023. Accessed October 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening [Link]

Related Statistics